Article Details

Recombinetics Inc. Announces Neurofibromatosis Type 1 Research Collaboration with AstraZeneca

Retrieved on: 2021-01-12 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Recombinetics Inc. Announces Neurofibromatosis Type 1 Research Collaboration with AstraZeneca. View article details on hiswai:

Excerpt

Together, AstraZeneca and Recombinetics Inc. will now undertake a study to assess selumetinib for the treatment of cutaneous neurofibromas, using ...

Article found on: www.southernminn.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up